China Macro Intelligence · Weekly Brief · Sample Issue
Tariff Whiplash and the ADR Discount
April 4, 2026 · CNY Trends Research Team · Est. read: 6 min
One year after Liberation Day, the US–China tariff relationship has settled into something more dangerous than a trade war: managed ambiguity. For funds holding Chinese ADRs, the risk is no longer the tariff level — it is the unpredictability of the regime itself.
China effective tariff rate
33.9%
Highest among major US trading partners · Jan 2026
US imports from China, 2025
−28%
40% below pre-trade-war 2018 levels
US goods deficit with China
$13.1B
February 2026 · Near 20-year low
BABA peak-to-current drawdown
−20%
From Oct 2025 high of $192
01 · The data
A year of decoupling, by the numbers
The tariff escalation of 2025 was the most aggressive bilateral trade action in a century. Washington raised tariffs on Chinese goods to 145% at peak — only to negotiate them back to roughly 10–30% by November. Then in February 2026, the Supreme Court struck down key IEEPA-based tariffs, forcing a complete policy reset.
The structural decoupling is now baked in. The easy supply chain moves out of China have already happened. What remains is harder to move, more sector-specific, and more consequential for portfolio companies.
April 2025
Liberation Day. Tit-for-tat escalation pushes tariffs to 145% on Chinese goods, 125% on US exports to China.
May 2025
Geneva truce. 90-day pause reduces China tariffs to 10%. ADRs recover 15–25% in weeks.
November 2025
Trump–Xi South Korea summit. Tariffs lowered to ~47%. Rare earths reopened. "Subscription diplomacy" model established — deals require annual renewal.
February 2026
Supreme Court strikes down IEEPA tariffs. New 10% global tariff announced under separate statute within days.
March 2026
New Section 301 investigations launched. USTR targets China and 15 economies. Public hearings April 28. New tariffs possible late 2026.
April 2026 · Now
Trump Beijing visit imminent. Both sides signaling stability — no substantive breakthrough yet. China ETR remains 33.9%.
02 · ADR breakdown
Three names, three risk profiles
Not all China ADR exposure is equal. Click each name to expand the full analysis.
BABA · NYSE
Alibaba Group
Tariff risk: Indirect
AI cloud pivot insulates from goods trade. Primary risk is delisting and VIE structure.
PDD · NASDAQ
PDD Holdings / Temu
Tariff risk: Direct
De minimis elimination hits Temu's US model at its core. Most exposed ADR to trade policy.
JD · NASDAQ
JD.com
Tariff risk: Moderate
Domestic China focus limits direct tariff exposure. Capital-intensive logistics buildout primary risk.
Alibaba's AI pivot is a genuine insulator. Cloud Intelligence Group holds 35.8% of China's AI cloud market, with revenue up 34% YoY in late 2025. Tariff exposure is largely indirect — the core business is domestically focused.
The real risks are structural, not tariff-driven. PCAOB audit access remains unresolved. VIE structure legal uncertainty is the other slow-burning risk. Model BABA as a geopolitical options trade — binary outcomes on audit access, with AI cloud as the underlying value anchor.
Temu is the clearest tariff casualty in the ADR space. The entire business model was built on the de minimis exemption — goods under $800 shipped direct-to-consumer duty-free. That loophole is gone.
Stress-test scenario: If Section 301 investigations produce new tariffs on cross-border e-commerce by late 2026, Temu's US business faces existential pressure. Any fund with PDD exposure should run a zero-Temu-US-revenue scenario on the underlying valuation.
JD's domestic fortress model is its tariff shield. Core business is Chinese domestic logistics and e-commerce — largely insulated from US tariff actions. Direct US revenue exposure is minimal.
The risk is a different equation. JD is a domestic China macro bet, not a trade war bet. The relevant signal is Chinese consumer confidence and property stabilization — not the bilateral tariff rate.
03 · Portfolio risk framework
Three categories — which bucket are your holdings in?
Risk driver
Section 301 outcomes
New tariffs possible on cross-border e-commerce and manufacturing inputs by late 2026.
Who's affected
Temu, consumer hardware, EV supply chains
Companies with meaningful US revenue derived from Chinese-manufactured goods.
Key date
April 28 Section 301 hearing
USTR public hearing on excess capacity investigations. Finding determines scope and timeline.
Primarily financial asset risk. VIE structure and delisting are the tail risks that matter.
Key signal
PCAOB audit access
Any restriction on auditor access re-triggers the delisting clock. Binary risk on a multi-year timeline.
Risk driver
Input cost inflation
US portfolio companies sourcing from China face higher COGS. Competitors face pricing pressure from subsidized Chinese exports.
Who's affected
Hardware, industrials, consumer manufacturing
US companies with Chinese manufacturing exposure or competing against Chinese players in ASEAN and EU markets.
Key signal
Trump–Xi summit outcome
A broader trade agreement could stabilize input costs. Failure re-opens the Section 301 escalation path.
04 · The signal going forward
What to watch in the next 90 days
The imminent Trump–Xi Beijing summit is the highest-stakes bilateral event of 2026. The base case is managed tension, not resolution. Expect continued ADR volatility of 8–15% on bilateral news events.
CNY Trends base case · April 2026
The tariff story has entered a more complex phase where the risk is legal ambiguity and policy unpredictability rather than raw tariff levels. That is harder to hedge and harder to model — which is exactly where a China-specific research lens earns its keep.
Section 301 public hearing — Sets timeline for potential new tariff action on manufacturing and tech goods.
Apr 28, 2026
Trump–Xi Beijing summit — Binary for ADR sentiment. Outcome determines whether managed stability continues or escalation accelerates.
Late Apr / May 2026
MOFCOM retaliation signal — China launched two WTO investigations in March. Findings could trigger new export controls.
Ongoing · Q2 2026
PBOC CNY pressure — Any break above 7.40 on USD/CNY signals capital flow stress and risk-off for ADRs.
Continuous
November 2026 deal renewal — The November 2025 truce requires annual renewal. Failure re-opens the tariff escalation pathway.
Nov 2026
Choosing a selection results in a full page refresh.